Mizuho Medy Co.,Ltd.

TSE:4595.T

1426 (JPY) • At close August 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Revenue 2,6493,4403,3211,9262,7422,999.3273,414.782,183.8632,391.7654,300.3615,967.7133,125.4664,188.292,550.7144,057.6483,903.7562,374.1521,710.756828.873611.081,052.5942,299.6711,280.4591,031.0311,815.7492,152.6631,176.923943.1872,152.3092,058.4541,036.452897.8241,631.2462,019.423789.112689.081,464.5741,468.088
Cost of Revenue 7451,085870604786829.507763.634635.698686.8481,038.6961,059.498566.79816.773717.392730.423919.616866.775441.505362.799274.332365.88755.593386.016362.674583.317687.74445.597320.011645.227657.992443.407304.526558.931725.677355.417207.374483.166520.73
Gross Profit 1,9042,3552,4511,3221,9562,169.822,651.1461,548.1651,704.9173,261.6654,908.2152,558.6763,371.5171,833.3223,327.2252,984.141,507.3771,269.251466.074336.748686.7141,544.078894.443668.3571,232.4321,464.923731.326623.1761,507.0821,400.462593.045593.2981,072.3151,293.746433.695481.706981.408947.358
Gross Profit Ratio 0.7190.6850.7380.6860.7130.7230.7760.7090.7130.7580.8220.8190.8050.7190.820.7640.6350.7420.5620.5510.6520.6710.6990.6480.6790.6810.6210.6610.70.680.5720.6610.6570.6410.550.6990.670.645
Reseach & Development Expenses 078300164193159163.466154185147152121161137135159509000461000460000386000356000306
General & Administrative Expenses 011300011100010300098000920009000084000780007100065
Selling & Marketing Expenses 0-23000503.148000565.6730002240003840001,0530001,0440009910001,004000727
SG&A 780918814731539614.148606.253508.94523.253668.673640.968574.066507.161642.834646.044602.148470.539476576464688446798616850441634596955466581581784460517530792327
Other Expenses 046-1020.3540.5722.133.7731.8181.5760.8432.9740.154-1.6010.1991.9220.1060.2040.3110.210.2090.2410.5130.587-9.9310.2060.3660.486-0.120.3110.8320.315-3.670.3130.8340.3262.328
Operating Expenses 780919813731703807.148765.253672.406677.253853.668787.968726.066628.161803.829783.044737.148629.539613.812575.999464.248688.503963.322798.575616.077850.252920.753633.488596.077955.47861.979580.913581.43784.355495.603516.879530.539792.185343.32
Operating Income 1,1241,4361,6385911,2531,362.6721,885.893875.7581,027.6632,407.9914,120.2481,832.612,743.3551,029.4872,544.1812,246.992877.837655.436-109.926-127.5-1.788580.7595.86952.279382.179544.16497.83927.099551.611538.47912.13311.869287.958472.232-83.183-48.832189.221305.569
Operating Income Ratio 0.4240.4170.4930.3070.4570.4540.5520.4010.430.560.690.5860.6550.4040.6270.5760.370.383-0.133-0.209-0.0020.2530.0750.0510.210.2530.0830.0290.2560.2620.0120.0130.1770.234-0.105-0.0710.1290.208
Total Other Income Expenses Net -60173-161118120-65.91456.687126.85722.856-110.84873.14-0.6685.0580.12430.58579.65715.652-0.209-0.4420.112-0.51159.004-0.3131.085-0.069-9.909-0.3340.410.9120.0240.0050.5930.065-5.7560.230.7050.114-15.536
Income Before Tax 1,0641,6091,4777091,3721,296.7581,942.581,002.6151,050.5192,297.1434,193.3881,831.9422,748.4131,029.6112,574.7662,326.649893.489655.227-110.368-127.388-2.299639.75495.55653.364382.11534.25597.50527.509552.524538.50412.13712.461288.023466.476-82.953-48.127189.335290.033
Income Before Tax Ratio 0.4020.4680.4450.3680.50.4320.5690.4590.4390.5340.7030.5860.6560.4040.6350.5960.3760.383-0.133-0.208-0.0020.2780.0750.0520.210.2480.0830.0290.2570.2620.0120.0140.1770.231-0.105-0.070.1290.198
Income Tax Expense 287386416189402350.143576.463287.523304.103591.561,264.586545.289831.356294.158789.721681.815242.048176.751-31.984-37.1811.24181.897-7.28511.449110.378134.16216.258-6.946149.113120.772-8.189-1.60780.1110.353-23.388-19.62962.18973.527
Net Income 7771,2231,061519970946.6141,366.118715.0917461,705.5822,928.8021,286.6531,917.057735.4521,785.0451,644.834651.441478.476-78.385-90.206-3.539457.857102.84141.915271.731400.09381.24634.455403.411417.73220.32614.068207.923356.123-59.565-28.499127.146216.506
Net Income Ratio 0.2930.3560.3190.2690.3540.3160.40.3270.3120.3970.4910.4120.4580.2880.440.4210.2740.28-0.095-0.148-0.0030.1990.080.0410.150.1860.0690.0370.1870.2030.020.0160.1270.176-0.075-0.0410.0870.147
EPS 40.7964.227.8527.25101.8499.39143.4375.0878.37179.07307.5135.09201.2838.6193.71172.768.450.19-8.23-9.47-0.3748.0910.814.4128.53428.612.3842.3587.772.25.8821.83149.5-25.01-11.9713.35100.22
EPS Diluted 40.7964.227.8527.25101.8499.39143.4375.0878.37179.07307.5135.09201.2838.6193.71172.768.450.19-8.23-9.47-0.3748.0910.814.4128.53428.612.3842.3587.772.25.8821.83149.5-25.01-11.9713.35100.22
EBITDA 1,1311,4941,685.755901,301.751,348.9271,885.893875.7591,073.52,344.6254,240.8641,878.7932,793.1981,073.3592,617.6912,370.286937.02703-68.75-76.22539.25622.2512190.1407534.52697.80627.713552.882538.76512.42712.778288.622467.119-82.516-47.382190.525291.234
EBITDA Ratio 0.4270.4340.5080.3060.4750.450.5520.4010.4490.5450.7110.6010.6670.4210.6450.6070.3950.411-0.083-0.1250.0370.2710.0940.0870.2240.2480.0830.0290.2570.2620.0120.0140.1770.231-0.105-0.0690.130.198